Interestingly, treatment of T2D mice with OA tended to reduce G6Pase RNA (∼30%, p = 0.09, Fig. 9B), while the level of PEPCK expression remained unchanged. The gene discussed is G6PC1; the disease is type 2 diabetes mellitus.